Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PODOMOUNT-Basket phase 2 study of BI 764198 in proteinuric kidney diseases
CTR20261305Phase 2Active
- Sponsor
- Boehringer Ingelheim
- Start
- May 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of apecotrep in proteinuric kidney disease, sponsored by Boehringer Ingelheim. Started May 2026; status: active.
02
Drugs
apecotrep
03
Conditions
proteinuric kidney disease
Beyond the preview
Go deeper on CTR20261305.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20261305.